Literature DB >> 34588447

Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9.

Daniel M Sapozhnikov1, Moshe Szyf2.   

Abstract

Despite four decades of research to support the association between DNA methylation and gene expression, the causality of this relationship remains unresolved. Here, we reaffirm that experimental confounds preclude resolution of this question with existing strategies, including recently developed CRISPR/dCas9 and TET-based epigenetic editors. Instead, we demonstrate a highly effective method using only nuclease-dead Cas9 and guide RNA to physically block DNA methylation at specific targets in the absence of a confounding flexibly-tethered enzyme, thereby enabling the examination of the role of DNA demethylation per se in living cells, with no evidence of off-target activity. Using this method, we probe a small number of inducible promoters and find the effect of DNA demethylation to be small, while demethylation of CpG-rich FMR1 produces larger changes in gene expression. This method could be used to reveal the extent and nature of the contribution of DNA methylation to gene regulation.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34588447      PMCID: PMC8481236          DOI: 10.1038/s41467-021-25991-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  135 in total

Review 1.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

2.  Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector.

Authors:  Maja Klug; Michael Rehli
Journal:  Epigenetics       Date:  2006-08-28       Impact factor: 4.528

3.  Transcription of IAP endogenous retroviruses is constrained by cytosine methylation.

Authors:  C P Walsh; J R Chaillet; T H Bestor
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

4.  TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation.

Authors:  Garrett A Kaas; Chun Zhong; Dawn E Eason; Daniel L Ross; Raj V Vachhani; Guo-Li Ming; Jennifer R King; Hongjun Song; J David Sweatt
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

5.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

Authors:  R Jüttermann; E Li; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain.

Authors:  Carina Frauer; Thomas Hoffmann; Sebastian Bultmann; Valentina Casa; M Cristina Cardoso; Iris Antes; Heinrich Leonhardt
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

7.  Progressive accumulation of epigenetic heterogeneity during human ES cell culture.

Authors:  Borko Tanasijevic; Bo Dai; Toshihiko Ezashi; Kimberly Livingston; R Michael Roberts; Theodore P Rasmussen
Journal:  Epigenetics       Date:  2009-07-15       Impact factor: 4.528

8.  Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.

Authors:  Laura Wiehle; Günter Raddatz; Tanja Musch; Meelad M Dawlaty; Rudolf Jaenisch; Frank Lyko; Achim Breiling
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 5.069

9.  Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.

Authors:  Morgan L Maeder; James F Angstman; Marcy E Richardson; Samantha J Linder; Vincent M Cascio; Shengdar Q Tsai; Quan H Ho; Jeffry D Sander; Deepak Reyon; Bradley E Bernstein; Joseph F Costello; Miles F Wilkinson; J Keith Joung
Journal:  Nat Biotechnol       Date:  2013-10-09       Impact factor: 54.908

10.  TETs compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers.

Authors:  Jocelyn Charlton; Eunmi J Jung; Alexandra L Mattei; Nina Bailly; Jing Liao; Eric J Martin; Pay Giesselmann; Björn Brändl; Elena K Stamenova; Franz-Josef Müller; Evangelos Kiskinis; Andreas Gnirke; Zachary D Smith; Alexander Meissner
Journal:  Nat Genet       Date:  2020-06-08       Impact factor: 38.330

View more
  8 in total

Review 1.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

Review 2.  Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.

Authors:  Daniel M Sapozhnikov; Moshe Szyf
Journal:  Nat Protoc       Date:  2022-10-07       Impact factor: 17.021

3.  Epigenome editing and epigenetic gene regulation in disease phenotypes.

Authors:  Gaochen Jin; Bomyi Lim
Journal:  Korean J Chem Eng       Date:  2022-03-15       Impact factor: 3.146

4.  Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox.

Authors:  Jessica A Kretzmann; Kelly L Irving; Nicole M Smith; Cameron W Evans
Journal:  NAR Cancer       Date:  2021-12-22

5.  Epigenome editing reveals core DNA methylation for imprinting control in the Dlk1-Dio3 imprinted domain.

Authors:  Shin Kojima; Naoya Shiochi; Kazuki Sato; Mamiko Yamaura; Toshiaki Ito; Nodoka Yamamura; Naoki Goto; Mika Odamoto; Shin Kobayashi; Tohru Kimura; Yoichi Sekita
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 19.160

6.  DNA methylation analysis of normal colon organoids from familial adenomatous polyposis patients reveals novel insight into colon cancer development.

Authors:  Matthew A Devall; Stephen Eaton; Mourad Wagdy Ali; Christopher H Dampier; Daniel Weisenberger; Steven M Powell; Li Li; Graham Casey
Journal:  Clin Epigenetics       Date:  2022-08-23       Impact factor: 7.259

7.  Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.

Authors:  Maxine Umeh-Garcia; Henriette O'Geen; Catalina Simion; Melanie Hayden Gephart; David J Segal; Colleen A Sweeney
Journal:  Br J Cancer       Date:  2022-04-19       Impact factor: 9.075

8.  Activation of stably silenced genes by recruitment of a synthetic de-methylating module.

Authors:  Wing Fuk Chan; Hannah D Coughlan; Yunshun Chen; Christine R Keenan; Gordon K Smyth; Andrew C Perkins; Timothy M Johanson; Rhys S Allan
Journal:  Nat Commun       Date:  2022-09-23       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.